Sarah Hawk, PA

NPI: 1588632897
Total Payments
$21,842
2024 Payments
$2,746
Companies
9
Transactions
46
Medicare Patients
43
Medicare Billing
$2,724

Payment Breakdown by Category

Consulting$14,013 (64.2%)
Travel$5,444 (24.9%)
Food & Beverage$1,714 (7.8%)
Other$660.00 (3.0%)
Education$11.33 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $14,013 9 64.2%
Travel and Lodging $5,444 16 24.9%
Food and Beverage $1,714 17 7.8%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $660.00 3 3.0%
Education $11.33 1 0.1%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $11,418 15 $0 (2023)
Genentech USA, Inc. $6,566 16 $0 (2024)
GENZYME CORPORATION $2,957 6 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $732.00 4 $0 (2023)
Bayer Healthcare Pharmaceuticals Inc. $65.08 1 $0 (2023)
BioMarin Pharmaceutical Inc. $60.00 1 $0 (2023)
Y-mAbs Therapeutics, Inc. $16.59 1 $0 (2023)
Incyte Corporation $15.44 1 $0 (2023)
PFIZER INC. $11.33 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,746 6 GENZYME CORPORATION ($2,708)
2023 $724.15 8 GENZYME CORPORATION ($249.94)
2022 $10,304 14 Novo Nordisk Inc ($6,554)
2021 $8,068 18 Novo Nordisk Inc ($4,620)

All Payment Transactions

46 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
11/21/2024 Genentech USA, Inc. Hemlibra (Biological) Food and Beverage In-kind items and services $15.09 General
Category: Hematology
09/11/2024 GENZYME CORPORATION Consulting Fee Cash or cash equivalent $2,483.00 General
09/11/2024 GENZYME CORPORATION Food and Beverage In-kind items and services $124.47 General
09/11/2024 GENZYME CORPORATION Travel and Lodging Cash or cash equivalent $83.08 General
09/11/2024 GENZYME CORPORATION Travel and Lodging Cash or cash equivalent $16.95 General
08/13/2024 Genentech USA, Inc. Hemlibra (Biological) Food and Beverage In-kind items and services $23.17 General
Category: Hematology
09/07/2023 Y-mAbs Therapeutics, Inc. DANYELZA (Drug) Food and Beverage Cash or cash equivalent $16.59 General
Category: Oncology
05/11/2023 Incyte Corporation JAKAFI (Drug) Food and Beverage Cash or cash equivalent $15.44 General
Category: Hematology/Oncology
03/12/2023 BioMarin Pharmaceutical Inc. Food and Beverage In-kind items and services $60.00 General
03/11/2023 Takeda Pharmaceuticals U.S.A., Inc. Food and Beverage In-kind items and services $72.00 General
03/11/2023 Bayer Healthcare Pharmaceuticals Inc. Jivi (Drug) Food and Beverage In-kind items and services $65.08 General
Category: Hematology
03/10/2023 Novo Nordisk Inc Rebinyn (Biological) Food and Beverage In-kind items and services $245.10 General
Category: Hemophilia
03/09/2023 GENZYME CORPORATION Food and Beverage In-kind items and services $124.97 General
03/09/2023 GENZYME CORPORATION Food and Beverage In-kind items and services $124.97 General
10/21/2022 Genentech USA, Inc. HEMLIBRA (Biological) Consulting Fee Cash or cash equivalent $2,375.00 General
Category: Hematology
10/21/2022 Genentech USA, Inc. HEMLIBRA (Biological) Travel and Lodging In-kind items and services $570.31 General
Category: Hematology
10/21/2022 Genentech USA, Inc. HEMLIBRA (Biological) Travel and Lodging In-kind items and services $284.60 General
Category: Hematology
10/21/2022 Genentech USA, Inc. HEMLIBRA (Biological) Food and Beverage Cash or cash equivalent $87.56 General
Category: Hematology
10/21/2022 Genentech USA, Inc. HEMLIBRA (Biological) Travel and Lodging Cash or cash equivalent $79.36 General
Category: Hematology
10/21/2022 Genentech USA, Inc. HEMLIBRA (Biological) Travel and Lodging Cash or cash equivalent $24.00 General
Category: Hematology
09/30/2022 Novo Nordisk Inc Consulting Fee Cash or cash equivalent $2,707.50 General
09/30/2022 Novo Nordisk Inc Travel and Lodging In-kind items and services $1,401.75 General
09/30/2022 Novo Nordisk Inc Travel and Lodging In-kind items and services $1,015.55 General
09/30/2022 Novo Nordisk Inc Travel and Lodging In-kind items and services $596.98 General
09/30/2022 Novo Nordisk Inc Food and Beverage In-kind items and services $261.78 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2022 1 11 12 $4,272 $655.16
2021 1 15 18 $4,211 $1,131
2020 1 17 18 $4,050 $938.28
Total Patients
43
Total Services
48
Medicare Billing
$2,724
Procedure Codes
3

All Medicare Procedures & Services

3 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 11 12 $4,272 $655.16 15.3%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 15 18 $4,211 $1,131 26.9%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 17 18 $4,050 $938.28 23.2%

About Sarah Hawk, PA

Sarah Hawk, PA is a Physician Assistant healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588632897.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sarah Hawk, PA has received a total of $21,842 in payments from pharmaceutical and medical device companies, with $2,746 received in 2024. These payments were reported across 46 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($14,013).

As a Medicare-enrolled provider, Hawk has provided services to 43 Medicare beneficiaries, totaling 48 services with total Medicare billing of $2,724. Data is available for 3 years (2020–2022), covering 3 distinct procedure/service records.

Practice Information

  • Specialty Physician Assistant
  • Location Oklahoma City, OK
  • Active Since 03/11/2006
  • Last Updated 07/03/2008
  • Taxonomy Code 363A00000X
  • Entity Type Individual
  • NPI Number 1588632897

Products in Payments

  • HEMLIBRA (Biological) $6,528
  • NovoSeven (Biological) $380.00
  • Rebinyn (Biological) $245.10
  • Jivi (Drug) $65.08
  • Hemlibra (Biological) $38.26
  • DANYELZA (Drug) $16.59
  • JAKAFI (Drug) $15.44
  • BENEFIX (Biological) $11.33

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Physician Assistant Doctors in Oklahoma City